President and Patient Advocate at KidneyCAN in Philadelphia, Pennsylvania.
Unmet Needs and Future Perspectives in the Treatment of RCC
Bryan Lewis, president of KidneyCAN, and Chung-Han Lee, MD, describe unmet needs and future perspectives in the treatment of renal cell carcinoma.
The Importance of Patients Advocating for Themselves During Their RCC Journey
Meryl Uranga describes her path with metastatic clear cell renal cell carcinoma after first treatment, and how it has affected her outlook on her life and future.
Quality-of-Life with Systemic Therapies in Metastatic Clear Cell RCC
A look at how to consider quality-of-life clinical trial and patient-reported data when treating clear cell renal cell carcinoma with combination therapies.
Patient Experience with Systemic Therapy-Related Toxicities in Metastatic RCC
Meryl Uranga describes her personal experience with managing the side effects of treatment for clear cell renal cell carcinoma.
Adverse Events Associated with IO-TKI Therapies in Metastatic Clear Cell RCC
An overview of side effects commonly seen with lenvatinib plus pembrolizumab for the treatment of clear cell renal cell carcinoma.
Role of Nurses in the Multidisciplinary Management of RCC
Clinical nurse Kiran Virdee explains why a multidisciplinary treatment approach to clear cell renal cell carcinoma is beneficial.
Factors for Consideration in RCC Treatment Decision-Making
An oncologist describes the necessity of discussing options with a patient when picking a treatment approach for clear cell renal cell carcinoma.
Lenvatinib + Pembrolizumab for the Treatment of Metastatic Clear Cell RCC
A review of clinical trial data on combination treatments for clear cell renal cell carcinoma.
A Patient’s Perspective on Choosing Systemic Therapy for Metastatic RCC
Patients with clear cell renal cell carcinoma speak to their experiences with systemic treatments.
First-Line Treatment Options for Metastatic Clear Cell RCC
An overview of first-line treatment options for metastatic clear cell renal cell carcinoma.
Patient Education Resources for RCC
Bryan Lewis, president of KidneyCAN, explains how his organization supports the renal cell carcinoma community and where patients can find curated educational resources.
Receiving a Diagnosis of Metastatic RCC: A Patient’s Journey
Patient Meryl Uranga describes how she was diagnosed with metastatic clear cell renal cell carcinoma and the initial treatments she received.
Overview of Clear Cell RCC
Chung-Han Lee, M.D., provides background on clear cell renal cell carcinoma, including common symptoms and risk factors.
